Kriegsmann, M., Rössler, S., Kriegsmann, K., Renner, M., Longuespée, R., Albrecht, T., . . . Goeppert, B. (2019). Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma: Correlation with clinicopathological data and comparison of antibodies. BMC cancer, 19, . https://doi.org/10.1186/s12885-018-5254-0
Chicago-Zitierstil (17. Ausg.)Kriegsmann, Mark, et al. "Programmed Cell Death Ligand 1 (PD-L1, CD274) in Cholangiocarcinoma: Correlation with Clinicopathological Data and Comparison of Antibodies." BMC Cancer 19 (2019). https://doi.org/10.1186/s12885-018-5254-0.
MLA-Zitierstil (9. Ausg.)Kriegsmann, Mark, et al. "Programmed Cell Death Ligand 1 (PD-L1, CD274) in Cholangiocarcinoma: Correlation with Clinicopathological Data and Comparison of Antibodies." BMC Cancer, vol. 19, 2019, https://doi.org/10.1186/s12885-018-5254-0.